Growth Metrics

Q32 Bio (QTTB) Income from Continuing Operations (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Income from Continuing Operations data on record, last reported at 45879000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 423.34% year-over-year to 45879000.0; the TTM value through Dec 2025 reached 17970000.0, up 138.97%, while the annual FY2025 figure was 16902000.0, 136.66% up from the prior year.
  • Income from Continuing Operations reached 45879000.0 in Q4 2025 per QTTB's latest filing, up from 7389000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 92696000.0 in Q1 2022 and bottomed at 33583000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 5858900.0, with a median of 12498500.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 8738.96% in 2022, then plummeted 1015.44% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 33583000.0 in 2021, then grew by 1.92% to 32938000.0 in 2022, then soared by 194.67% to 31182000.0 in 2023, then tumbled by 145.5% to 14189000.0 in 2024, then surged by 423.34% to 45879000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 45879000.0 in Q4 2025, 7389000.0 in Q3 2025, and 9489000.0 in Q2 2025.